Using drug chemical structures in the education of pharmacology and clinical therapeutics key concepts
DOI:
https://doi.org/10.1590/s2175-97902022e21070Keywords:
Medicinal chemistry, Structure, Pharmacy students, Pharmacology, Clinical therapeuticsAbstract
Medicinal chemistry made it possible for pharmacists to propose pharmacodynamics and pharmacokinetics explanations of many existing drugs. Moreover, medicinal chemistry education provides pharmacy students with a reasonable understanding of drug physicochemical properties, mechanism of action (MOA), side effects, metabolism and structure-activity relationship (SAR). This paper highlights the importance of these medicinal chemistry key elements in understanding other pharmacy core courses, mainly pharmacology and clinical therapeutics. Such elements can be utilized as a tool for pharmacists while training or counseling their patients on the use of their treatments. Different new examples from the literature have been incorporated in this paper to show how chemical structures of existing drugs can provide essential information about main concepts in the education of pharmacology and clinical therapeutics, and the key structural elements for the discovery and development of other same class drugs.
Downloads
References
Abou-Khalil BW. Oxcarbazepine and carbamazepine: Expected and unexpected differences and similarities. Epilepsy Curr. 2007;7(3):74-6.
Alsharif NZ, Destache CJ, Roche VF. Teaching medicinal chemistry to meet outcome objectives for pharmacy students. Am J Pharm Educ. 1999;63(1):34-40.
Alsharif NZ, Galt KA, Mehanna A, Chapman R, Ogunbadeniyi AM. Instructional Model to teach clinically relevant medicinal chemistry. Am J Pharm Educ . 2006;70(4):1-12.
Alsharif NZ, Theesen KA, Roche VF. Structurally Based therapeutic evaluation: a therapeutic and practical approach to teaching medicinal chemistry. Am J Pharm Educ . 1997;61(1):55-60.
Appiah-Ankam J, Hunter JM. Pharmacology of neuromuscular blocking drugs. Continuing Education in Anaesthesia Critical Care Pain. 2004;4(1):2-7.
Aungst BJ. Optimizing Oral Bioavailability in Drug Discovery: An Overview of design and testing strategies and formulation options. J Pharm Sci. 2017;106(4):921-9.
Baillie TA, Dalvie D, Rietjens IMCM, Khojasteh SC. Biotransformation and bioactivation reactions - 2015 literature highlights. Drug Metab Rev. 2016;48(2):113-38.
Benitez A, Edens H, Fishman J, Moran K, Asgharnejad M. Rotigotine Transdermal system: developing continuous dopaminergic delivery to treat parkinson’s disease and restless legs syndrome. Ann N Y Acad Sci. 2014;1329:45-66.
Björnsson E. Hepatotoxicity associated with antiepileptic drugs. Acta Neurol Scand. 2008;118(5):281-90.
Bowman WC. Neuromuscular block. Br J Pharmacol. 2006;147( Suppl 1):S277-86.
Brandt JT, Payne CD, Wiviott SD, Weerakkody G, Farid NA, Small DS, et al. A comparison of prasugrel and clopidogrel loading doses on platelet function: magnitude of platelet inhibition is related to active metabolite formation. Am Heart J. 2007;153(1):66.e9-16.
Brito MA de. Pharmacokinetic Study with Computational Tools in the Medicinal Chemistry Course. Braz J Pharm Sci . 2011;47(4):797-805.
Chernoloz O, El Mansari M, Blier P. Long-term administration of the dopamine D3/2 receptor agonist pramipexole increases dopamine and serotonin neurotransmission in the male rat forebrain. J Psychiatry Neurosci. 2012;37(2):113-21.
Currie BL, Chapman RL, Christoff JJ, Sikorski L. Patient-related case studies in medicinal chemistry. Am J Pharm Educ . 1994;58:5.
Dansette PM, Levent D, Hessani A, Mansuy D. Bioactivation of Clopidogrel and prasugrel: factors determining the stereochemistry of the thiol metabolite double bond. Chem Res Toxicol. 2015;28(6):1338-45.
Das J, Fernandez J, Shah D, Williams L, Zagaar M. Case-based Studies in teaching medicinal chemistry in PharmD curriculum: perspectives of students, faculty, and pharmacists from academia. Curr Pharm Teach Learn. 2018;10(1):85-9.
Farid NA, Kurihara A, Wrighton SA. Metabolism and disposition of the thienopyridine antiplatelet drugs ticlopidine, clopidogrel, and prasugrel in humans. J Clin Pharmacol. 2010;50(2):126-42.
Fernandes JPS. The Importance of medicinal chemistry knowledge in the clinical pharmacist’s education. Am J Pharm Educ . 2018;82(2):106-14.
Ferreira EI. Chemistry and pharmaceutical sciences always together. Braz J Pharm Sci . 2010;46(3):v-v.
Gubareva LV, Webster RG, Hayden FG. Comparison of the activities of Zanamivir, Oseltamivir, and RWJ-270201 against Clinical isolates of influenza virus and neuraminidase inhibitor-resistant variants. Antimicrob Agents Chemother. 2001;45(12):3403-8.
Gupta SV, Gupta D, Sun J, Dahan A, Tsume Y, Hilfinger J, et al. Enhancing the intestinal membrane permeability of Zanamivir: a carrier mediated prodrug approach. Mol Pharm. 2011;8(6):2358-67.
Hagihara K, Kazui M, Kurihara A, Yoshiike M, Honda K, Okazaki O, et al. A possible mechanism for the differences in efficiency and variability of active metabolite formation from thienopyridine antiplatelet agents, prasugrel and clopidogrel. Drug Metab Dispos. 2009;37(11):2145-52.
Higuchi S, Yano A, Takai S, Tsuneyama K, Fukami T, Nakajima M, et al. Metabolic Activation and inflammation reactions involved in carbamazepine-induced liver injury. Toxicol Sci. 2012;130(1):4-16.
Kalgutkar AS, Fate G, Didiuk MT, Bauman J. Toxicophores, reactive metabolites and drug safety: when is it a cause for concern? Expert Rev Clin Pharmacol. 2008;1(4):515-31.
Krueger JL. Pharmacy students’ application of knowledge from the classroom to introductory pharmacy practice experiences. Am J Pharm Educ . 2013;77(2):31.
Lee C. Structure, conformation, and action of neuromuscular blocking drugs. Br J Anaesth. 2001;87(5):755-69.
Lee C. Conformation, action, and mechanism of action of neuromuscular blocking muscle relaxants. Pharmacol Ther. 2003;98(2):143-69.
Li Y, Wang Z, Li X, Gong W, Xie X, Yang Y, et al. In vitro evaluation of absorption characteristics of peramivir for oral delivery. Eur J Drug Metab Pharmacokinet. 2017;42(5):757-65.
Ludbrook GL, Upton RN. Determinants of drug onset. Curr Opin Anaesthesiol. 2002;15(4):409-14.
Masimirembwa CM, Bredberg U, Andersson TB. Metabolic stability for drug discovery and development: pharmacokinetic and biochemical challenges. Clin Pharmacokinet. 2003;42(6):515-28.
Norgard NB, Abu-Fadel M. Comparison of Prasugrel and Clopidogrel in Patients with Acute Coronary Syndrome Undergoing Percutaneous Coronary Intervention. Vasc Health Risk Manag. 2009;5:873-82.
Ramsay RR, Popovic-Nikolic MR, Nikolic K, Uliassi E, Bolognesi ML. A perspective on multi-target drug discovery and design for complex diseases. Clin Transl Med. 2018;7:1-14.
Rautio J, Kumpulainen H, Heimbach T, Oliyai R, Oh D, Järvinen T, et al. Prodrugs: design and clinical applications. Nat Rev Drug Discov. 2008;7(3):255-70.
Salahudeen MS, Nishtala PS. An overview of pharmacodynamic modelling, ligand-binding approach and its application in clinical practice. Saudi Pharm J. 2017;25(2):165-75.
Satyanarayanajois SD. Active-learning exercises to teach drug-receptor interactions in a medicinal chemistry course. Am J Pharm Educ . 2010;74(8):1-9.
Schade D, Kotthaus J, Riebling L, Kotthaus J, Müller-Fielitz H, Raasch W, et al. Zanamivir amidoxime- and n-hydroxyguanidine-based prodrug approaches to tackle poor oral bioavailability. J Pharm Sci . 2015;104(9):3208-19.
Schmidt D, Elger CE. What is The Evidence that oxcarbazepine and carbamazepine are distinctly different antiepileptic drugs? Epilepsy Behav. 2004;5(5):627-35.
Shie J-J, Fang J-M. Development of effective anti-influenza drugs: congeners and conjugates - a review. J Biomed Sci. 2019;26(1):84.
Tatonetti NP, Liu T, Altman RB. Predicting drug side-effects by chemical systems biology. Genome Biol. 2009;10(9):238.
Varela FA, Der-Ghazarian T, Lee RJ, Charntikov S, Crawford CA, McDougall SA. Repeated aripiprazole treatment causes dopamine D2 receptor up-regulation and dopamine supersensitivity in young rats. J Psychopharmacol. 2014;28(4):376-86.
Veber DF, Johnson SR, Cheng H-Y, Smith BR, Ward KW, Kopple KD. Molecular properties that influence the oral bioavailability of drug candidates. J Med Chem. 2002;45(12):2615-23.
Waters C. The development of the rotigotine transdermal patch: a historical perspective. Neurol Clin. 2013;31(3 Suppl):S37-50.
Weerakkody GJ, Jakubowski JA, Brandt JT, Farid NA, Payne CD, Zhu J, et al. Comparison of speed of onset of platelet inhibition after loading doses of clopidogrel versus prasugrel in healthy volunteers and correlation with responder status. Am J Cardiol. 2007;100(2):331-6.
Wermuth CG, Ganellin CR, Lindberg P, Mitscher LA. Glossary of terms used in medicinal chemistry (IUPAC Recommendations 1998). Pure Appl Chem. 1998;70(5):1129-43.
Wong BS, Manabe N, Camilleri M. Role of prucalopride, a serotonin (5-HT4) receptor agonist, for the treatment of chronic constipation. Clin Exp Gastroenterol. 2010;3:49-56.
Downloads
Published
Issue
Section
License
Copyright (c) 2022 Brazilian Journal of Pharmaceutical Sciences
This work is licensed under a Creative Commons Attribution 4.0 International License.
All content of the journal, except where identified, is licensed under a Creative Commons attribution-type BY.
The on line journal has open and free access.
How to Cite
Funding data
-
Yarmouk University
Grant numbers 2020/37
